home | publications


1. P53 Regulates the expression of tumor suppressor gene maspin.
Zou Z, Gao C-L, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, and Srivastava S:
J. Biol. Chem. 275:6051-6054, 2000. (News and Views, Nature Medicine: Demystifying the mehanisms of maspin, 6:374-376, 2000).

2. Inflammatory Infiltrate (Prostatitis) in Whole Mounted Radical Prostatectomy Specimens from Black and White Patients is not an Etiology for Racial Difference in Prostate Specific Antigen.
Zhang W, Sesterhenn IA, Connelly RR, Mostofi FK, and Moul JW:
The Journal of Urology, 163:131-136, 2000.

3. PSGR, a novel prostate specific gene with homology to a G-protein coupled receptor is overexpressed in prostate cancer.
Xu LL, Stackhouse BG, Florence K, Zhang W, Shanmugam N, Sesterhenn IA, Zou Z, Srikantan V, Augustus M, Roschke V, Carter K, McLeod DG, Moul JW, Soppett D and Srivastava S:
Cancer Research, 60:6568-6572, 2000.

4. Expression Profile of an Androgen Regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
Xu L, Srikantan V, Sesterhenn IA, Augustus M, Dean R, Moul JW, Carter KC, and Srivastava, S.
J. Urol., 163:972-979, 2000.

5. Comparative Study of the Clinical Efficacy of Two Dosing Regimens of Flutamide.
Thrasher JB, Deeths J, Bennett C, Iyer P, Dineen MK, Zhai S, Figg WD, McLeod DG:
Mol Urol, 4 (3), 2000.

6. The Impact of Socioeconomic Status on Clinical Parameters of Radical Prostatectomy Patients in an equal access health care system.
Tarman GJ, Kane CJ, Moul JW, Thrasher JB, Foley J, White D, Riffenburgh RH, and Amling CL:
Urology 56: 1016-1020, 2000.

7. PCGEMI, A novel prostate specific gene is overexpressed in prostate cancer.
Srikantan V, Zou Z, Petrovics G, Xu LL, Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino K, Buzzard GS, Mostofi FK, McLeod DG, Moul JW, and Srivastava S:
Proc. Natl. Acad. Sci. USA 97:12216-12221, 2000.

8. Prostate Cancer in men 50 years of age of less: A review of the Department of Defense Center for Prostate Disease Research (CPDR) Multicenter Prostate Cancer Database.
Smith CV, Bauer JJ, Connelly RR, Seay T, Kane CJ, Foley J, Thrasher JB, Kusuda L, and Moul JW:
Journal of Urology Vol. 164: 1964-1967, 2000.

9. The role of pretreatment serum albumin to predict pathological stage and recurrence among radical prostatectomy cases.
Richter E, Connelly RR and Moul JJ:
Prostate Cancer and Prostatic Diseases Vol. 3: 186-190, 2000.

10. In vitro human cell culture models for the study of prostate cancer.
Rhim JS:
Prostate Cancer and Prostatic Diseases, 3:229-235, 2000.

11. Prostate Specific Antigen Levels in Young White and Black Men 20 to 45 Years Old.
Preston DM, Levin LI, Jacobson DJ, Jacobsen SJ, Rubertone M, Holmes E, Murphy GP and Moul JW:,
Urology, 56:5, 2000.

12. Treatment of Metastatic Prostate Cancer.
Moul JW:
Brazil J Urology, 26(2): 132-145, 2000.

13. Targeted screening for prostate cancer in African-American men.
Moul JW:
Prostate Cancer and Prostatic Diseases, 3:248-255, 2000.

14. Screening for Prostate Cancer in African Americans.
Moul JW:
Current Urology Reports 1: 57-64, 2000.

15. Prostate Specific Antigen only Progression of Prostate Cancer.
Moul JW:
The J. Urology, 163: 1632-1642, 2000.

16. Management of prostate specific antigen increase after definitive treatment of prostate cancer.
Moul JW:
AUA News, October 2000.

17. Hormonal Therapy Options for Biochemical Recurrence of Prostate Cancer after Local Therapy.
Moul JW:
Molecular Urology, 4:267-271, 2000.

18. The Role of Imaging Studies and Molecular Markers for Selecting Candidates for Radical Prostatectomy.
Moul JW, Kane CJ, and Malkowicz SB:
Urol., Clinics of North America, 2000.

19. Gynecomastia in Patients with Prostate Cancer: A Review of Treatment Options.
McLeod DG, Iverson P:
Urology, 213-720, 2000.

20. Multicenter Patient Self-Reporting Questionnaire on Impotence, Incontinence and Stricture After Radical Prostatectomy.
Kao TC, Cruess DF, Garner D, Foley J, Seay T, Friedrichs Jr. P, Brantley T, Mooneyhan TR, McLeod DG, and Moul JW:
The Journal of Urology, 163, 858-864, 2000.